ArticleLiver cancer2024

A Prospective, Single-Arm, Phase 2 Study of Modified Transarterial Chemoembolization Using Low-Dose Chemotherapy with Blank Microspheres Plus Low-Dose Lenvatinib and Microwave Ablation in Patients with Large (≥7 cm) Unresectable Hepatocellular Carcinoma: The TALEM Trial.

Zhi-Mei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.